News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Mark Frisse, MD*

Articles by Mark Frisse, MD*

Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy

ByEmily R. Cox, PhD,Brenda Motheral, PhD,Mark Frisse, MD*,Andrew Behm, PharmD,Doug Mager, BS

November 1st 2003

Latest Updated Articles

Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy
Published: November 1st 2003 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text